Obama’s Plan for a Bioeconomy

The White House announces a strategy to foster development of biological products in fields ranging from medicine to agriculture.

Written byMegan Scudellari
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ARS technicians assess biomass materials for biofuels production FLICKR, U.S DEPARTMENT OF AGRICULTURE

Yesterday (April 26), the White House released its “Bioeconomy Blueprint,” a strategy to spur the development of biological products in the United States, including medical treatments, crops, biofuels, and more.

“The bioeconomy has emerged as an Obama Administration priority because of its tremendous potential for growth as well as the many other societal benefits it offers,” said the document’s executive summary. The country’s current bioeconomy is centered on genetic engineering, DNA sequencing, and automated high-throughput manipulations of biomolecules, the report cited. Emerging technologies, it continued, include synthetic biology, proteomics, and bioinformatics.

Initial reactions from the biotech industry are positive. “Replacing chemistry with biology—fossil fuels with biofuels—puts steel in the ground, creates jobs, and powers our economy,” Adam Monroe, president of Denmark-based biotech Novozymes, told Biofuels ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies